Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution

Contact Us
If you have any questions or feedback please contact us.

Jennifer Taylor-Cousar

Concepts (323)

Concepts are derived automatically from a person's publications.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Cystic Fibrosis
118
2025
1100
22.080
Why?
Cystic Fibrosis Transmembrane Conductance Regulator
72
2025
335
14.770
Why?
Quinolones
29
2025
135
8.650
Why?
Aminophenols
44
2025
158
8.570
Why?
Benzodioxoles
30
2025
116
5.960
Why?
Chloride Channel Agonists
28
2025
85
4.870
Why?
Sinusitis
12
2025
237
3.790
Why?
Indoles
19
2025
411
3.230
Why?
Rhinitis
10
2025
171
2.980
Why?
Olfaction Disorders
8
2025
67
2.300
Why?
Pyrazoles
17
2025
425
2.130
Why?
Aminopyridines
6
2025
102
2.060
Why?
Drug Combinations
24
2025
346
1.920
Why?
Mutation
34
2024
3984
1.910
Why?
Pyrrolidines
12
2025
80
1.900
Why?
Membrane Transport Modulators
3
2020
7
1.830
Why?
Pongo pygmaeus
3
2024
6
1.800
Why?
Pyridines
15
2025
494
1.750
Why?
Pregnancy Complications
5
2024
538
1.660
Why?
Ape Diseases
3
2024
8
1.560
Why?
Reproductive Health
9
2024
91
1.380
Why?
Azithromycin
7
2021
97
1.290
Why?
Pregnancy Outcome
6
2024
428
1.280
Why?
Humans
127
2025
138972
1.220
Why?
Quality of Life
17
2025
2962
1.180
Why?
Pregnancy
20
2025
6870
1.130
Why?
Respiratory System Agents
2
2020
23
1.100
Why?
Reproductive Techniques, Assisted
3
2025
39
1.090
Why?
Parents
5
2024
1423
1.080
Why?
Adult
61
2025
38393
1.030
Why?
Paranasal Sinuses
5
2024
84
0.960
Why?
Female
73
2025
74016
0.940
Why?
Fetal Therapies
1
2025
45
0.900
Why?
Sexual Health
5
2024
59
0.880
Why?
Pseudomonas Infections
9
2024
221
0.880
Why?
Anti-Bacterial Agents
12
2024
1811
0.860
Why?
Drug Approval
3
2024
91
0.860
Why?
Pregnancy Rate
3
2021
67
0.850
Why?
Pongo
2
2021
6
0.830
Why?
Chronic Disease
14
2025
1804
0.830
Why?
Quinolines
6
2025
150
0.700
Why?
Prospective Studies
16
2025
7661
0.700
Why?
Lung Transplantation
1
2024
313
0.700
Why?
Diabetes Mellitus
2
2022
1068
0.680
Why?
Treatment Outcome
23
2025
10921
0.680
Why?
Infectious Disease Transmission, Patient-to-Professional
1
2020
20
0.680
Why?
Glucose Intolerance
2
2025
146
0.680
Why?
Male
57
2025
68250
0.660
Why?
Sweat
9
2025
47
0.650
Why?
Compassionate Use Trials
1
2019
7
0.640
Why?
Smell
4
2025
122
0.630
Why?
Aerosols
1
2020
181
0.630
Why?
Drug Monitoring
6
2020
209
0.620
Why?
Lung
9
2023
4103
0.620
Why?
Sputum
5
2022
305
0.610
Why?
Fertility
3
2025
164
0.600
Why?
Precision Medicine
2
2021
421
0.600
Why?
Pseudomonas aeruginosa
9
2022
348
0.600
Why?
Genetic Therapy
4
2025
314
0.590
Why?
Forced Expiratory Volume
11
2023
488
0.550
Why?
Drug-Related Side Effects and Adverse Reactions
1
2020
253
0.540
Why?
Aldehyde Oxidoreductases
1
2017
27
0.520
Why?
Breast Feeding
2
2022
434
0.520
Why?
Glucose Tolerance Test
2
2025
366
0.520
Why?
Child
24
2025
21936
0.510
Why?
Rifampin
1
2017
84
0.500
Why?
Pongo abelii
1
2016
1
0.500
Why?
Biomedical Research
3
2024
695
0.490
Why?
Chlorides
8
2025
138
0.480
Why?
Sildenafil Citrate
2
2014
59
0.460
Why?
Young Adult
23
2025
13371
0.460
Why?
Surveys and Questionnaires
11
2025
5884
0.450
Why?
Adolescent
25
2025
21581
0.440
Why?
Bronchiectasis
1
2016
111
0.440
Why?
Leukocyte Elastase
1
2014
75
0.440
Why?
Tobramycin
5
2019
52
0.440
Why?
Infertility, Male
2
2025
62
0.430
Why?
Prenatal Exposure Delayed Effects
1
2020
611
0.420
Why?
Respiratory Function Tests
6
2025
561
0.380
Why?
Double-Blind Method
10
2025
1949
0.380
Why?
Lactation
3
2022
179
0.370
Why?
Contraception Behavior
2
2025
105
0.360
Why?
Genotype
8
2025
1849
0.340
Why?
Homozygote
4
2021
202
0.340
Why?
Contraception
2
2025
161
0.340
Why?
Drug Interactions
4
2020
404
0.320
Why?
International Cooperation
2
2020
202
0.310
Why?
Hypoventilation
1
2009
13
0.310
Why?
Respiratory Muscles
1
2009
34
0.310
Why?
Alleles
8
2025
890
0.300
Why?
Blood Glucose
3
2025
2241
0.290
Why?
ABO Blood-Group System
1
2009
52
0.290
Why?
Clinical Trials as Topic
3
2025
1034
0.290
Why?
Parenting
2
2023
317
0.280
Why?
Tomography, X-Ray Computed
4
2022
2697
0.270
Why?
Needs Assessment
2
2020
381
0.260
Why?
Asthma
3
2024
1893
0.250
Why?
Polymorphism, Genetic
1
2009
624
0.240
Why?
Middle Aged
20
2025
33782
0.240
Why?
Phenylpropionates
1
2025
21
0.240
Why?
Observational Studies as Topic
2
2024
119
0.230
Why?
Off-Label Use
1
2025
53
0.230
Why?
United States
10
2025
15074
0.230
Why?
Oligonucleotides, Antisense
1
2025
110
0.230
Why?
Animals
10
2024
37243
0.230
Why?
Fertility Preservation
1
2024
52
0.210
Why?
Minimal Clinically Important Difference
1
2023
17
0.210
Why?
Infant, Newborn
4
2024
6158
0.210
Why?
Food Preferences
1
2025
124
0.210
Why?
Orphan Drug Production
1
2023
5
0.210
Why?
Pregnancy, Unplanned
2
2023
46
0.210
Why?
Patient Selection
2
2019
680
0.200
Why?
C-Reactive Protein
2
2018
411
0.200
Why?
Abortion, Spontaneous
1
2023
104
0.200
Why?
Biomarkers
5
2024
4095
0.200
Why?
Ion Transport
2
2021
60
0.190
Why?
Body Height
1
2023
197
0.190
Why?
Neonatal Screening
1
2024
167
0.190
Why?
Respiratory Tract Diseases
1
2024
181
0.190
Why?
Puberty
1
2023
152
0.190
Why?
Azabicyclo Compounds
1
2021
6
0.180
Why?
Epoxide Hydrolases
1
2021
13
0.180
Why?
Enzyme Activators
1
2021
9
0.180
Why?
Benzoates
1
2021
46
0.180
Why?
Dose-Response Relationship, Drug
2
2017
2047
0.180
Why?
RNA, Messenger
3
2022
2815
0.180
Why?
Men's Health
1
2020
6
0.170
Why?
Endoscopy
4
2024
320
0.170
Why?
Infertility
1
2021
55
0.170
Why?
Multicenter Studies as Topic
1
2022
321
0.170
Why?
Women's Rights
1
2020
4
0.160
Why?
Disease Progression
5
2020
2752
0.160
Why?
Retrospective Studies
10
2024
15901
0.160
Why?
Communicable Disease Control
1
2020
83
0.160
Why?
Virulence Factors
2
2014
160
0.160
Why?
Cataract
1
2022
221
0.160
Why?
Aztreonam
2
2016
11
0.160
Why?
Colistin
1
2019
8
0.160
Why?
Health Knowledge, Attitudes, Practice
2
2025
1377
0.150
Why?
Follow-Up Studies
3
2024
5152
0.150
Why?
Sexism
1
2020
67
0.150
Why?
Neutrophils
3
2016
1274
0.150
Why?
Medication Therapy Management
1
2020
77
0.150
Why?
Receptors, Interleukin-8B
1
2018
26
0.150
Why?
Health Status
1
2023
823
0.140
Why?
Administration, Oral
1
2020
787
0.140
Why?
Patient Reported Outcome Measures
1
2022
416
0.140
Why?
Research Design
1
2024
1120
0.140
Why?
Severity of Illness Index
5
2021
2849
0.140
Why?
Pyrimidines
1
2021
472
0.140
Why?
Mental Health
1
2024
742
0.140
Why?
Cytochrome P-450 CYP3A Inducers
1
2017
6
0.130
Why?
Pregnancy, High-Risk
1
2017
15
0.130
Why?
HEK293 Cells
1
2020
731
0.130
Why?
Leukocytes
1
2018
308
0.130
Why?
Risk Assessment
3
2021
3466
0.130
Why?
Longitudinal Studies
1
2024
2850
0.130
Why?
Respiratory Tract Infections
1
2021
383
0.130
Why?
Biological Availability
1
2017
137
0.130
Why?
Biphenyl Compounds
1
2017
61
0.130
Why?
Research
1
2020
451
0.130
Why?
Risk Adjustment
1
2017
81
0.130
Why?
Prognosis
2
2022
3995
0.120
Why?
Health Services Accessibility
2
2024
993
0.120
Why?
Methicillin-Resistant Staphylococcus aureus
1
2019
234
0.120
Why?
Recovery of Function
1
2020
665
0.120
Why?
Gene Expression Profiling
3
2018
1746
0.120
Why?
Albuterol
1
2016
74
0.120
Why?
Pharmacogenetics
1
2017
164
0.120
Why?
Attitude of Health Personnel
1
2023
1159
0.120
Why?
Adrenal Cortex Hormones
1
2018
496
0.120
Why?
Machine Learning
1
2020
516
0.110
Why?
Interferons
1
2016
195
0.110
Why?
Pilot Projects
2
2020
1765
0.110
Why?
Child, Preschool
3
2024
11158
0.110
Why?
Epithelial Cells
2
2020
1103
0.110
Why?
Diabetes Complications
1
2016
224
0.110
Why?
Cyclopropanes
2
2025
69
0.110
Why?
Bronchodilator Agents
1
2016
197
0.110
Why?
Phosphodiesterase 5 Inhibitors
1
2014
36
0.110
Why?
Staphylococcal Infections
1
2019
387
0.110
Why?
Metalloproteases
1
2014
42
0.110
Why?
DNA Mutational Analysis
1
2015
397
0.110
Why?
Genetic Predisposition to Disease
2
2015
2362
0.110
Why?
Quorum Sensing
1
2014
77
0.100
Why?
Body Mass Index
2
2023
2390
0.100
Why?
Administration, Inhalation
3
2022
595
0.100
Why?
Neutrophil Activation
1
2013
85
0.100
Why?
Wound Infection
1
2013
35
0.100
Why?
Mycobacterium Infections
1
2013
62
0.100
Why?
Cellular Structures
1
2011
6
0.090
Why?
Comorbidity
1
2016
1657
0.090
Why?
Mycobacterium
1
2013
110
0.090
Why?
Drug Therapy, Combination
3
2021
1031
0.090
Why?
Extracellular Space
1
2011
129
0.090
Why?
Microbial Viability
1
2011
91
0.090
Why?
Blood Glucose Self-Monitoring
1
2016
684
0.090
Why?
Patient Admission
1
2012
202
0.080
Why?
Risk Factors
3
2020
10385
0.080
Why?
Leukocytes, Mononuclear
1
2013
571
0.080
Why?
Infant
1
2024
9577
0.080
Why?
Survival Rate
2
2018
1934
0.080
Why?
Cardiovascular Diseases
1
2021
2058
0.080
Why?
Blood Group Antigens
1
2009
16
0.070
Why?
Aged
5
2024
24172
0.070
Why?
Inflammation
2
2022
2853
0.070
Why?
Burns
1
2013
340
0.070
Why?
Mucus
1
2009
78
0.070
Why?
Mass Screening
1
2016
1296
0.070
Why?
Inpatients
1
2012
505
0.070
Why?
ADP Ribose Transferases
1
2007
9
0.070
Why?
Exotoxins
1
2007
16
0.070
Why?
Furin
1
2007
14
0.070
Why?
Sexual Behavior
2
2022
488
0.070
Why?
3',5'-Cyclic-GMP Phosphodiesterases
1
2007
18
0.070
Why?
Time Factors
3
2024
6869
0.070
Why?
Cyclic GMP
1
2007
91
0.070
Why?
Oxygen Inhalation Therapy
1
2009
172
0.070
Why?
Bacterial Toxins
1
2007
104
0.070
Why?
Gene Expression Regulation
1
2016
2591
0.070
Why?
Phenotype
1
2015
3143
0.070
Why?
Sulfones
1
2007
110
0.060
Why?
Registries
3
2023
2081
0.060
Why?
Survivors
1
2010
501
0.060
Why?
Respiratory System
1
2007
157
0.060
Why?
Quinoxalines
1
2025
67
0.060
Why?
Respiratory Mucosa
1
2007
322
0.060
Why?
Piperazines
1
2007
345
0.060
Why?
European Union
1
2024
12
0.060
Why?
Respiration, Artificial
1
2009
670
0.050
Why?
Reproductive Health Services
1
2023
19
0.050
Why?
Standard of Care
1
2024
77
0.050
Why?
Cross-Sectional Studies
2
2025
5530
0.050
Why?
Logistic Models
2
2019
2093
0.050
Why?
United States Food and Drug Administration
1
2024
205
0.050
Why?
Nose
1
2023
65
0.050
Why?
Anemia, Iron-Deficiency
1
2024
59
0.050
Why?
Cell Separation
2
2016
317
0.050
Why?
Deoxyribonuclease I
1
2022
39
0.050
Why?
Saline Solution, Hypertonic
1
2022
41
0.050
Why?
Rare Diseases
1
2023
108
0.050
Why?
Sex Education
1
2022
30
0.050
Why?
Social Class
1
2024
278
0.050
Why?
Hot Flashes
1
2023
87
0.050
Why?
Contraceptive Agents
1
2022
66
0.050
Why?
Microbial Sensitivity Tests
2
2014
348
0.050
Why?
Iron
1
2024
324
0.040
Why?
Health Status Disparities
1
2024
299
0.040
Why?
Polymorphism, Single Nucleotide
1
2009
2138
0.040
Why?
Biofilms
2
2014
266
0.040
Why?
Preconception Care
1
2021
42
0.040
Why?
Nutritional Status
1
2023
353
0.040
Why?
Genetic Counseling
1
2021
79
0.040
Why?
Social Determinants of Health
1
2024
260
0.040
Why?
Attitude
1
2022
260
0.040
Why?
Societies, Medical
1
2024
835
0.040
Why?
Longevity
1
2021
174
0.040
Why?
Contraceptives, Oral, Hormonal
1
2020
34
0.040
Why?
Menopause
1
2023
326
0.040
Why?
Condoms
1
2020
102
0.040
Why?
Ambulatory Care
1
2023
575
0.040
Why?
Tetraspanin 30
1
2018
10
0.040
Why?
Sequence Analysis, DNA
1
2022
824
0.040
Why?
Administration, Intravenous
1
2019
156
0.040
Why?
British Columbia
1
2018
21
0.040
Why?
Genetic Testing
1
2021
453
0.040
Why?
Sex Factors
1
2024
2050
0.040
Why?
Ecosystem
1
2023
573
0.040
Why?
Diabetes Mellitus, Type 2
1
2012
2516
0.040
Why?
Healthcare Disparities
1
2024
662
0.030
Why?
trans-Golgi Network
2
2007
14
0.030
Why?
Case-Control Studies
2
2016
3574
0.030
Why?
Gene Deletion
1
2018
389
0.030
Why?
Nitric Oxide Synthase Type II
2
2007
174
0.030
Why?
Morbidity
1
2018
321
0.030
Why?
Drug Administration Routes
1
2016
41
0.030
Why?
Cells, Cultured
2
2018
4182
0.030
Why?
Genetic Variation
1
2021
990
0.030
Why?
Leadership
1
2020
394
0.030
Why?
Interferon-alpha
1
2016
195
0.030
Why?
Practice Patterns, Physicians'
1
2023
1321
0.030
Why?
Medication Adherence
1
2018
505
0.030
Why?
Colorado
2
2018
4543
0.030
Why?
Depression
1
2024
1470
0.030
Why?
Drug Resistance, Multiple, Bacterial
1
2014
74
0.030
Why?
Kaplan-Meier Estimate
1
2016
897
0.030
Why?
Rats
1
2022
5591
0.030
Why?
Odds Ratio
1
2016
1084
0.030
Why?
Survival Analysis
1
2016
1311
0.020
Why?
Cohort Studies
1
2023
5744
0.020
Why?
Ciprofloxacin
1
2013
26
0.020
Why?
Multivariate Analysis
1
2016
1497
0.020
Why?
Real-Time Polymerase Chain Reaction
1
2013
348
0.020
Why?
Superoxides
1
2013
217
0.020
Why?
Drug Synergism
1
2013
367
0.020
Why?
Suspensions
1
2011
27
0.020
Why?
Cell Line
2
2007
2879
0.020
Why?
Enteral Nutrition
1
2012
202
0.020
Why?
Cell Adhesion
1
2011
466
0.020
Why?
Age Distribution
1
2010
401
0.020
Why?
Sex Distribution
1
2010
380
0.020
Why?
Aged, 80 and over
1
2021
7685
0.020
Why?
Age of Onset
1
2010
521
0.020
Why?
Insulin Infusion Systems
1
2012
447
0.020
Why?
Predictive Value of Tests
1
2013
2030
0.020
Why?
Feedback, Physiological
1
2007
81
0.020
Why?
Cyclic Nucleotide Phosphodiesterases, Type 5
1
2007
22
0.020
Why?
Epithelial Sodium Channels
1
2007
21
0.020
Why?
Guanylate Cyclase
1
2007
38
0.020
Why?
Sodium
1
2007
196
0.020
Why?
Purines
1
2007
179
0.020
Why?
Hydrogen-Ion Concentration
1
2007
557
0.020
Why?
In Vitro Techniques
1
2007
1090
0.010
Why?
Transforming Growth Factor beta
1
2007
488
0.010
Why?
Patient Acceptance of Health Care
1
2010
856
0.010
Why?
Hypoglycemic Agents
1
2012
1343
0.010
Why?
Mice
2
2013
17828
0.010
Why?
Disease Models, Animal
1
2013
4316
0.010
Why?
Nitric Oxide
1
2007
892
0.010
Why?
Mice, Transgenic
1
2007
2171
0.010
Why?
Insulin
1
2012
2447
0.010
Why?
Macrophages
1
2007
1543
0.010
Why?
Signal Transduction
1
2007
5092
0.010
Why?
Taylor-Cousar's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Co-Authors Expand Description
_
Similar People Expand Description
_
Same Department Expand Description
Physical Neighbors Expand Description
_

Copyright © 2026 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)